384 related articles for article (PubMed ID: 31769579)
1. Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates.
Vallat JM; Mathis S; Vegezzi E; Richard L; Duchesne M; Gallouedec G; Corcia P; Magy L; Uncini A; Devaux J
Eur J Neurol; 2020 Apr; 27(4):692-701. PubMed ID: 31769579
[TBL] [Abstract][Full Text] [Related]
2. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural mechanisms of macrophage-induced demyelination in CIDP.
Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Neurology; 2018 Dec; 91(23):1051-1060. PubMed ID: 30429275
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Samarasekera S
Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
[TBL] [Abstract][Full Text] [Related]
6. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory demyelinating polyneuropathy.
Said G
Neuromuscul Disord; 2006 May; 16(5):293-303. PubMed ID: 16631367
[TBL] [Abstract][Full Text] [Related]
8. [Histopathological features of chronic inflammatory demyelinating polyradiculoneuropathy].
Maisonobe T
Rev Neurol (Paris); 2006 Apr; 162(4):527-32. PubMed ID: 16585916
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyneuropathy associated with dysglobulinemia: a peripheral nerve biopsy study in 18 cases.
Vital A; Lagueny A; Julien J; Ferrer X; Barat M; Hermosilla E; Rouanet-Larrivière M; Henry P; Bredin A; Louiset P; Herbelleau T; Boisseau C; Guiraud-Chaumeil B; Steck A; Vital C
Acta Neuropathol; 2000 Jul; 100(1):63-8. PubMed ID: 10912921
[TBL] [Abstract][Full Text] [Related]
10. Pathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies.
Vallat JM; Mathis S
Brain Pathol; 2024 Mar; 34(2):e13184. PubMed ID: 37356965
[TBL] [Abstract][Full Text] [Related]
11. [Immune-mediated neuropathies: indications and value of nerve biopsy].
Verschueren A
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S58-60. PubMed ID: 18087231
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases.
Vallat JM; Tabaraud F; Magy L; Torny F; Bernet-Bernady P; Macian F; Couratier P
Muscle Nerve; 2003 Apr; 27(4):478-85. PubMed ID: 12661050
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory demyelinating polyradiculoneuropathy with tumefactive central demyelination.
Krivickas LS; Hochberg FH; Freeman S
Muscle Nerve; 2006 Feb; 33(2):283-8. PubMed ID: 16086427
[TBL] [Abstract][Full Text] [Related]
14. [Chronic inflammatory demyelinating polyneuropathy].
Köller H; Kieseier BC; Jander S; Hartung HP
Nervenarzt; 2003 Apr; 74(4):320-33. PubMed ID: 12707701
[TBL] [Abstract][Full Text] [Related]
15. Different distribution of demyelination in chronic inflammatory demyelinating polyneuropathy subtypes.
Shibuya K; Tsuneyama A; Misawa S; Sekiguchi Y; Beppu M; Suichi T; Suzuki YI; Nakamura K; Kano H; Kuwabara S
J Neuroimmunol; 2020 Apr; 341():577170. PubMed ID: 32006783
[TBL] [Abstract][Full Text] [Related]
16. The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies.
Querol LA; Hartung HP; Lewis RA; van Doorn PA; Hammond TR; Atassi N; Alonso-Alonso M; Dalakas MC
Neurotherapeutics; 2022 Apr; 19(3):864-873. PubMed ID: 35378684
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
Devaux JJ
Am J Pathol; 2012 Oct; 181(4):1402-13. PubMed ID: 22885108
[TBL] [Abstract][Full Text] [Related]
18. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
Eur J Neurol; 2011 Feb; 18(2):293-299. PubMed ID: 20602631
[TBL] [Abstract][Full Text] [Related]
19. [Structural characteristics of sural nerve myelin from patients with chronic inflammatory demyelinating polyneuropathy: an X-ray diffraction study].
Vargas Leal V; Cotúa Salazar M; Borges Iturriza J; Vonasek Golcz E; Vargas R; Céspedes-Caravaca G; Mateu-Suay L
Rev Neurol; 2003 Apr 1-15; 36(7):614-9. PubMed ID: 12666039
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyradiculoneuropathy with histologically proven optic neuritis.
Holtkamp M; Zschenderlein R; Brück W; Weber JR
Acta Neuropathol; 2001 May; 101(5):529-31. PubMed ID: 11484826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
